Prediction of the Disposition of Beta-lactam Antibiotics in Humans from Pharmacokinetic Parameters in Animals

Overview

Journal J Pharmacokinet Biopharm

Specialty Pharmacology

Date 1984 Jun 1

PMID 6438301

Citations 31

Authors

Y Sawada

M Hanano

Y Sugiyama

T Iga

Affiliations

Soon will be listed here.

Abstract

Various pharmacokinetic parameters (disposition half-life, total body clearance, renal clearance, hepatic clearance, volume of distribution, intrinsic clearance and volume of distribution of unbound drug) of six beta-lactam antibiotics were compared in mouse, rat, rabbit, dog, monkey, and human. Two methods for prediction of the disposition of the beta-lactam antibiotics in humans by extrapolation of the animal data were evaluated. One was the Adolph-Dedrick approach, which can be used to predict clearances in humans from the relationship between intrinsic clearances and body weight in the other five species. The volume of distribution in humans was predicted from the relationship between the volume of distribution and serum unbound fraction in the five species. The other was the Boxenbaum approach, which can be used to predict the pharmacokinetic parameters of the six beta-lactam antibiotics in humans by using the regression lines of log-log plots of intrinsic clearance and volume of distribution of unbound drug in a single species, in this case the monkey. The half-life calculated according to the latter method had a smaller absolute error than that calculated according to the former method, but the better method for extrapolation of animal data to humans seems to be the former method, which does not require a priori information regarding structure-pharmacokinetic relationships among the antibiotics.

Citing Articles

ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs.

Chaira T, Subramani C, Barman T Pharmaceutics. 2023; 15(4).

PMID: 37111697 PMC: 10146820. DOI: 10.3390/pharmaceutics15041212.

Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans.

Bamfo N, Hosey-Cojocari C, Benet L, Remsberg C Pharm Res. 2021; 38(7):1139-1156.

PMID: 34254223 PMC: 9855226. DOI: 10.1007/s11095-021-03076-y.

In vivo evaluation of drug dialyzability in a rat model of hemodialysis.

Fukunaga M, Kadowaki D, Mori M, Hagiwara S, Narita Y, Saruwatari J PLoS One. 2020; 15(6):e0233925.

PMID: 32530952 PMC: 7292355. DOI: 10.1371/journal.pone.0233925.

Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling.

Choi G, Lee Y, Cho H Pharmaceutics. 2019; 11(4).

PMID: 30959827 PMC: 6523982. DOI: 10.3390/pharmaceutics11040168.

Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future.

Smith P, Zuccotto F, Bates R, Martinez-Martinez M, Read K, Peet C ACS Infect Dis. 2018; 4(10):1439-1447.

PMID: 30141902 PMC: 6189874. DOI: 10.1021/acsinfecdis.8b00160.

References

Sugita O, Sawada Y, Sugiyama Y, Iga T, Hanano M . Effect of sulfaphenazole on tolbutamide distribution in rabbits: analysis of interspecies differences in tissue distribution of tolbutamide. J Pharm Sci. 1984; 73(5):631-4. DOI: 10.1002/jps.2600730513. View

Benowitz N, Forsyth F, Melmon K, Rowland M . Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model. Clin Pharmacol Ther. 1974; 16(1):87-98. DOI: 10.1002/cpt1974161part187. View

Kemmerich B, Lode H, Belmega G, Jendroschek T, Borner K, Koeppe P . Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam. Antimicrob Agents Chemother. 1983; 23(3):429-34. PMC: 184665. DOI: 10.1128/AAC.23.3.429. View

Tsuji A, Miyamoto E, Terasaki T, Yamana T . Physiological pharmacokinetics of beta-lactam antibiotics: penicillin V distribution and elimination after intravenous administration in rats. J Pharm Pharmacol. 1979; 31(2):116-9. DOI: 10.1111/j.2042-7158.1979.tb13448.x. View

Harashima H, Sawada Y, Sugiyama Y, Iga T, Hanano M . Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics. J Pharmacokinet Biopharm. 1985; 13(4):425-40. DOI: 10.1007/BF01061478. View

Igari Y, Sugiyama Y, Sawada Y, Iga T, Hanano M . Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model. J Pharmacokinet Biopharm. 1983; 11(6):577-93. DOI: 10.1007/BF01059058. View

Dedrick R, Forrester D, Cannon J, MELLETT L . Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine (ARA-C) deamination in several species. Biochem Pharmacol. 1973; 22(19):2405-17. DOI: 10.1016/0006-2952(73)90342-0. View

Dedrick R . Animal scale-up. J Pharmacokinet Biopharm. 1973; 1(5):435-61. DOI: 10.1007/BF01059667. View

Matsui H, Yano K, Okuda T . Pharmacokinetics of the cephalosporin SM-1652 in mice, rats, rabbits, dogs, and rhesus monkeys. Antimicrob Agents Chemother. 1982; 22(2):213-7. PMC: 183713. DOI: 10.1128/AAC.22.2.213. View

10.

MELLETT L . Comparative drug metabolism. Prog Drug Res. 1969; 13:136-69. DOI: 10.1007/978-3-0348-7068-9_3. View

11.

Bischoff K, Dedrick R, ZAHARKO D, Longstreth J . Methotrexate pharmacokinetics. J Pharm Sci. 1971; 60(8):1128-33. DOI: 10.1002/jps.2600600803. View

12.

Boxenbaum H . Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J Pharmacokinet Biopharm. 1982; 10(2):201-27. DOI: 10.1007/BF01062336. View

13.

Levy G . Effect of plasma protein binding on renal clearance of drugs. J Pharm Sci. 1980; 69(4):482-3. DOI: 10.1002/jps.2600690437. View

14.

Klotz U, Antonin K, Bieck P . Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. J Pharmacol Exp Ther. 1976; 199(1):67-73. View

15.

Nakagawa K, Koyama M, Tachibana A, Komiya M, Kikuchi Y, Yano K . Pharmacokinetics of cefotetan (YM09330) in humans. Antimicrob Agents Chemother. 1982; 22(6):935-41. PMC: 185696. DOI: 10.1128/AAC.22.6.935. View

16.

Wilkinson G, SHAND D . Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther. 1975; 18(4):377-90. DOI: 10.1002/cpt1975184377. View

17.

Katz J, BONORRIS G, Golden S, SELLERS A . Extravascular albumin mass and exchange in rat tissues. Clin Sci. 1970; 39(6):705-24. DOI: 10.1042/cs0390705. View

18.

Tsuji A, Yoshikawa T, NISHIDE K, Minami H, Kimura M, Nakashima E . Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats. J Pharm Sci. 1983; 72(11):1239-52. DOI: 10.1002/jps.2600721103. View

19.

Prokesch R, Hand W . Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1982; 21(3):373-80. PMC: 181898. DOI: 10.1128/AAC.21.3.373. View

20.

ADOLPH E . Quantitative Relations in the Physiological Constitutions of Mammals. Science. 1949; 109(2841):579-85. DOI: 10.1126/science.109.2841.579. View